The passing of the first recipient of a genetically modified pig kidney transplant has been announced, marking a somber turn of events just two months after the groundbreaking operation took place.
Massachusetts General Hospital (MGH), the institution responsible for conducting the procedure in March, shared the news on Sunday, May 12, revealing that Richard “Rick” Slayman, aged 62, had passed away. Notably, medical authorities clarified that there were no indications suggesting that Mr. Slayman’s demise was directly linked to the transplant procedure.
Despite the setbacks experienced with previous attempts at transplanting organs from genetically modified pigs, Mr. Slayman’s operation had been celebrated as a historic breakthrough. Suffering from end-stage kidney disease alongside Type 2 diabetes and hypertension, he had undergone a human kidney transplant in 2018, only to face complications as the organ began to fail after five years.
Following the successful pig kidney transplant on March 16, Mr. Slayman’s medical team confirmed that he no longer required dialysis, indicating that the newly transplanted organ was functioning effectively.
In a statement, MGH expressed deep sadness at Mr. Slayman’s unexpected passing, extending heartfelt condolences to his family during this difficult time. Additionally, they hailed Mr. Slayman as a symbol of hope for countless individuals awaiting transplants worldwide, recognizing his pivotal role in advancing the field of xenotransplantation—the process of transplanting living cells, tissues, or organs from one species to another.
Relatives of Mr. Slayman reflected on his legacy, emphasizing his desire to provide hope to others in need of life-saving transplants. Describing him as a compassionate individual with a sharp sense of humor and unwavering dedication to his loved ones, they celebrated his enduring spirit and optimism.
While Mr. Slayman’s case marked the first instance of a pig kidney being transplanted into a human, it is not the initial foray into using pig organs for transplantation purposes. Previous attempts at pig heart transplants for two other patients proved unsuccessful, with recipients tragically passing away within weeks of the procedure. These outcomes underscore the inherent risks associated with transplant procedures, including the potential for rejection by the recipient’s immune system—a challenge that remains a focal point for ongoing research and medical advancements in the field.
